93
Participants
Start Date
January 31, 2012
Primary Completion Date
August 31, 2014
Study Completion Date
May 31, 2016
Blinatumomab
Administered by continuous intravenous infusion
St. Anna Kinderspital, Vienna
Memorial Sloan Kettering, New York
Charité Campus Virchow Klinikum, Otto-Heubner-Centrum (OHC) für Kinder- und Jugendmedizin, Berlin
Children's Hospital of Philadelphia, Philadelphia
University of Milano-Bicocca, Hospital San Gerardo, Monza
(CHU Besancon) Hopital Saint-Jaques, Besançon
Children's Healthcare of Atlanta at Egleston, Atlanta
Universitätsklinikum Düsseldorf, Düsseldorf
Cincinnati Children's Hospital Medical Center, Cincinnati
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt/Main, Frankfurt am Main
Universitätsklinik für Kinder- und Jugendmedizin Tübingen, Tübingen
Hopital Robert Debré (AP-HP), Paris
Children's Hospital Denver, Aurora
Klinikum der Universität München, Dr. von Haunersches Kinderspital, München
Seattle Children's Hospital, Seattle
Washington University, St Louis
Primary Children's Medical Center, Salt Lake City
Hôpital de la Timone (Enfants), Marseille
Universitätsklinikum Essen, Essen
Universitätsklinikum Hamburg-Eppendorf, Hamburg
Medizinische Hochschule Hannover, Hanover
Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel
Universitätsklinikum Würzburg, Würzburg
Dipartimento della Donna e del Bambino, Padua
St Jude Children's Research Hospital, Memphis
UT Southwestern Medical Center, Dallas
Texas Children's Cancer Center/ Baylor, Houston
Hospital for Sick Children, Toronto
The Bambino Gesù Children's Hospital, Rome
Erasmus MC, Sophia Children's Hospital, Rotterdam
Amgen Research (Munich) GmbH
INDUSTRY